Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

New drug uses show promise but need more research.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

CGRP-IR axons may help maintain and renew tissues.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Valproic acid and crocin together boost cell growth and may help treat nerve injuries.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

ExoFlo is safe and effective for treating Complex Regional Pain Syndrome symptoms.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Botulinum toxin is effectively used to treat various painful conditions and its therapeutic uses are growing.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.